A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable sector in the EU.
Linnea, a Swiss provider of ingredients for the pharmaceutical, cosmetics, and dietary supplement industries, has two applications now on hold with the European Food Safety Authority (EFSA).
...
Need help?
Contact a sales representative right now and don’t wait
“ Swiss CBD company takes issue with EFSA’s delay of novel food applications ”
Buy report request information:
“ Swiss CBD company takes issue with EFSA’s delay of novel food applications ”
A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable sector in the EU.
Linnea, a Swiss provider of ingredients for the pharmaceutical, cosmetics, and dietary supplement industries, has two applications now on hold with the European Food Safety Authority (EFSA).
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
